Correlation Between Green Cross and PanGen Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Green Cross and PanGen Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Green Cross and PanGen Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Green Cross Lab and PanGen Biotech, you can compare the effects of market volatilities on Green Cross and PanGen Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Green Cross with a short position of PanGen Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Green Cross and PanGen Biotech.

Diversification Opportunities for Green Cross and PanGen Biotech

-0.65
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Green and PanGen is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding Green Cross Lab and PanGen Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PanGen Biotech and Green Cross is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Green Cross Lab are associated (or correlated) with PanGen Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PanGen Biotech has no effect on the direction of Green Cross i.e., Green Cross and PanGen Biotech go up and down completely randomly.

Pair Corralation between Green Cross and PanGen Biotech

Assuming the 90 days trading horizon Green Cross Lab is expected to under-perform the PanGen Biotech. But the stock apears to be less risky and, when comparing its historical volatility, Green Cross Lab is 1.18 times less risky than PanGen Biotech. The stock trades about -0.04 of its potential returns per unit of risk. The PanGen Biotech is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  609,000  in PanGen Biotech on August 30, 2024 and sell it today you would lose (9,000) from holding PanGen Biotech or give up 1.48% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Green Cross Lab  vs.  PanGen Biotech

 Performance 
       Timeline  
Green Cross Lab 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Green Cross Lab has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
PanGen Biotech 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in PanGen Biotech are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, PanGen Biotech sustained solid returns over the last few months and may actually be approaching a breakup point.

Green Cross and PanGen Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Green Cross and PanGen Biotech

The main advantage of trading using opposite Green Cross and PanGen Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Green Cross position performs unexpectedly, PanGen Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PanGen Biotech will offset losses from the drop in PanGen Biotech's long position.
The idea behind Green Cross Lab and PanGen Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Transaction History
View history of all your transactions and understand their impact on performance
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments